Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT‐PD‐L1 Axis

Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT‐PD‐L1 Axis

Abstract Immunotherapy targeting PD‐L1 is still ineffective for a wide variety of tumors with high unpredictability. Deploying combined immunotherapy with alternative targeting is practical to overcome this therapeutic resistance. Here, the deficiency of serine‐threonine kinase STK24 is observed in...

Full description

Bibliographic Details
Main Authors: Ning Wang, Yu Jiang, Mengjie Li, Haofei Wang, Jie Pan, Yang Tang, Shaofang Xie, Yunyang Xu, Xu Li, Xuefei Zhou, Pinglong Xu, Wenlong Lin, Xiaojian Wang
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Advanced Science
Subjects:
AKT
programmed cell death ligand 1 (PD‐L1)
serine/threonine protein kinase 24 (STK24)
tumor immune evasion
Online Access:https://doi.org/10.1002/advs.202304342

Internet

https://doi.org/10.1002/advs.202304342

Similar Items